About Swedish Orphan International
Swedish Orphan International (SOI) specializes in the development, marketing and distribution of pharmaceutical products, focusing on orphan drugs (niche products) with unmet medical needs that can be used in the treatment of rare disorders and life-threatening diseases.
SOI markets some 40 products, of which two are proprietary and the rest licensed from partners such as Chiron, Cephalon, Giliad, Shire and Actelion.
For more information visit www.swedishorphan.com
